scientific-regulatory-science

Cross-agency regulatory profiles consolidate FDA, EMA, and PMDA approval histories, safety signals, and classifications into structured JSON or CSV outputs with unified identifiers, dates, and statuses. This enables rapid assembly of comprehensive timelines and milestones for pharmaceuticals, medical devices, and combination products.

Cross-agency approval history checks query FDA, EMA, and PMDA databases simultaneously to retrieve classifications, recalls, and milestones for combination products. This generates a unified regulatory report containing structured timelines, safety signals, and compliance summaries across multiple jurisdictions.

USPTO patent searches and FDA Orange Book data can be cross-referenced for competitive intelligence and freedom-to-operate analysis. This identifies patent expiries and landscapes, returning structured outputs with patent identifiers, statuses, and dates to support strategic pharmaceutical planning.

ISO 13485 CAPA planning aligns with regulatory compliance by integrating quality-management requirements and risk mitigation into the regulatory profile. This consolidates safety data and recall histories to support corrective actions, producing structured outputs that map compliance milestones to quality standards.

Cross-database regulatory querying supports JSON and CSV exports by consolidating FDA, EMA, PMDA, and IP source data into structured outputs. These formats contain standardized identifiers, approval dates, statuses, and summaries, enabling direct integration into downstream regulatory reporting and analysis workflows.

Limitations of cross-agency regulatory data consolidation include reliance on available FDA, EMA, and PMDA dataset structures and IP source coverage. It does not replace official agency certifications, and structured outputs require manual validation for complex combination products where classification definitions differ across jurisdictions.